@abangelabs.bsky.socialPregnancy signals can outrank live-birth evidence in chronic endometritis. See why endpoint hierarchy matters in network meta-analysis. https://www.mattheneus.com/editorial/pubmed-chronic-endometritis-nma-live-birth-endpoint-hierarchy-2026-10-08 #HTA #NMA #EvidenceSynthesis
@abangelabs.bsky.socialCollagenopathy evidence supports phenotype-specific preterm birth risk assessment. https://www.mattheneus.com/editorial/acta-collagenopathies-marfan-ehlers-danlos-spontaneous-preterm-birth-2026-10-09 #HTA #EvidenceSynthesis #RWE
@abangelabs.bsky.socialMalaria and schistosomiasis coinfection exceeds chance levels, a meta-analysis finds. https://www.mattheneus.com/editorial/pubmed-malaria-schistosomiasis-coinfection-overdispersion-meta-analysis-2026-10-09 #HTA #EvidenceSynthesis #RWE
@abangelabs.bsky.socialTime-specific estimands can determine whether a paediatric antiemetic network answers the clinical question you intended. https://www.mattheneus.com/editorial/paediatric-antiemetic-nma-time-window-estimand-governance-2026-10-04 #HTA #NMA #EvidenceSynthesis
@abangelabs.bsky.socialIQWiG sets an evidence agenda for identifying and phasing out low-value care. #HTA #HealthEconomics #EvidenceSynthesis https://www.mattheneus.com/editorial/iqwig-low-value-care-identification-deimplementation-evidence-agenda-2026-10-06
@abangelabs.bsky.socialNew meta-analysis links apixaban with lower VTE recurrence and major bleeding versus rivaroxaban. #HTA #EvidenceSynthesis #Pharma https://www.mattheneus.com/editorial/pubmed-apixaban-rivaroxaban-vte-recurrence-major-bleeding-meta-analysis-2026-10-09
@abangelabs.bsky.socialFeasibility comes before adjustment: CIDP shows why population, outcome, and pooling checks determine whether MAIC can support credible HTA evidence. https://www.mattheneus.com/editorial/cidp-maic-feasibility-population-outcome-pooling-checks-2026-10-09 #HTA #MAIC #EvidenceSynthesis
@abangelabs.bsky.socialFive studies set a clear evidence boundary for near-patient tuberculosis testing. Here is what the diagnostic accuracy evidence supports. #HTA #EvidenceSynthesis #HealthEconomics https://www.mattheneus.com/editorial/cochrane-near-point-of-care-tuberculosis-minidock-diagnostic-accuracy-2026-10-09
@abangelabs.bsky.socialWhich postoperative sedative best reduces delirium, and what trade-offs follow? This network meta-analysis maps the benefit-risk picture. #HTA #NMA #EvidenceSynthesis https://www.mattheneus.com/editorial/pubmed-dexmedetomidine-postoperative-intensive-care-delirium-bradycardia-network-2026-10-02
@abangelabs.bsky.socialWhich lifestyle options improve cardiometabolic outcomes in PCOS? A Bayesian network analysis maps the evidence. #HTA #NMA #EvidenceSynthesis https://www.mattheneus.com/editorial/pubmed-polycystic-ovary-syndrome-lifestyle-bayesian-network-meta-analysis-2026-10-09
@abangelabs.bsky.socialA German consultation on pulmonary embolism thrombectomy puts population fit under the spotlight. https://www.mattheneus.com/editorial/g-ba-in-toto-thrombectomy-pulmonary-embolism-consultation-population-fit-2026-10-08 #HTA #EvidenceSynthesis #RegulatoryAffairs
@abangelabs.bsky.socialCrohn's disease location can reshape comparative treatment efficacy and the network meta-analysis question. https://www.mattheneus.com/editorial/pubmed-crohns-disease-location-treatment-efficacy-nma-2026-10-08 #HTA #NMA #EvidenceSynthesis
@abangelabs.bsky.socialFrench reassessment highlights how outcomes evidence can reshape reimbursement decisions. https://www.mattheneus.com/editorial/has-zimino-levosimendan-reassessment-insufficient-clinical-benefit-2026-08-26 #HTA #EvidenceSynthesis #Pharma
@abangelabs.bsky.socialHow do perioperative chemotherapy cycle strategies compare in gastric cancer? A new network meta-analysis maps the evidence. #HTA #NMA #EvidenceSynthesis https://www.mattheneus.com/editorial/world-journal-gastric-cancer-perioperative-cycle-network-meta-analysis-2026-10-08
@abangelabs.bsky.socialSeven new studies left this living treatment network's conclusions unchanged. See what quarterly surveillance reveals. https://www.mattheneus.com/editorial/pubmed-living-nma-quarterly-surveillance-stable-conclusions-2026-10-08 #HTA #NMA #EvidenceSynthesis
@abangelabs.bsky.socialA zero-event study can leave exploratory dressing comparisons unresolved. See how unanchored MAIC frames the residual uncertainty.
https://www.mattheneus.com/editorial/sacral-dressing-unanchored-maic-residual-differences-2026-10-07
#HTA #MAIC #EvidenceSynthesis #HealthEconomics
@abangelabs.bsky.socialA 55-study review maps treatment de-escalation across 13 atopic dermatitis regimens. https://www.mattheneus.com/editorial/pubmed-atopic-dermatitis-treatment-deescalation-network-meta-analysis-2026-10-03 #HTA #NMA #EvidenceSynthesis
@abangelabs.bsky.socialPortugal’s EU JCA alignment map shows that outcome scoping carries the largest methodology gap. https://www.mattheneus.com/editorial/portugal-eu-jca-methodology-alignment-outcome-scoping-gaps-2026-10-07 #HTA #EvidenceSynthesis #RegulatoryAffairs
@abangelabs.bsky.socialWHO updates pre-eclampsia evidence across magnesium sulfate, aspirin and calcium, sharpening priorities for maternal health. https://www.mattheneus.com/editorial/who-pre-eclampsia-fact-sheet-magnesium-aspirin-calcium-evidence-2026-10-06 #HTA #EvidenceSynthesis #HealthEconomics
@abangelabs.bsky.socialArm-wise target matching is now available for anchored MAIC in AbangeLabs HTA Studio. https://www.mattheneus.com/editorial/abangelabs-hta-studio-anchored-maic-weighting-strategy-arm-wise-target-matching-2026-10-08 #HTA #MAIC #EvidenceSynthesis